NEWS & EVENTS
Patient getting blood transfusion in hospital clinic.

2022 State of the Science in Transfusion Medicine Symposium

August 29 - 30, 2022
Videocast
Day 1: 10 a.m.-3 p.m. ET
Day 2: 10 a.m.-3:30 p.m. ET

Description

The NHLBI, in collaboration with the DHHS Office of the Assistant Secretary for Health, is hosting the 2022 State of the Science in Transfusion Medicine virtual symposium August 29-30. The purpose of the symposium is to help identify current basic, translational, and clinical research priorities that, if addressed in the next decade, would:

  • Increase and diversify the volunteer blood donor pool
  • Identify donor blood products that would best match the needs of specific recipient populations
  • Help ensure safe and effective transfusion strategies

Six NHLBI working groups have identified draft research priorities:

  • Blood donors and the supply
  • Optimizing transfusion outcomes for recipients
  • Emerging infections
  • Mechanistic aspects of components and transfusion
  • New methods in transfusion science: Data science, multifactorial analyses, use of artificial intelligence/machine learning
  • Donor and blood recipient health disparities in transfusion medicine

Representatives of each working group will present these draft research priorities for their areas of focus to obtain input from all meeting participants.

Videocast

Watch via videocast:

Day 1: https://videocast.nih.gov/watch=46107
Day 2: https://videocast.nih.gov/watch=46109

Submit your questions in advance or during the event to NHLBI2022Sos@nhlbi.nih.gov.

Contact

For logistical questions or if you require special accommodations to participate, contact Rashawn Jones. For questions about the program, contact Simone Glynn or Benyam Hailu.

Agenda

10:00 – 10:10 a.m.
-
Welcome and Introduction

Julie A. Panepinto, M.D., M.S.P.H., Acting Division Director, Division of Blood Diseases and Resources, NHLBI, NIH

Admiral Rachel Levine, M.D., Assistant Secretary of Health, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services

10:10 – 10:15 a.m.
-
Purpose of the State of the Science

Brian Custer, Ph.D., M.P.H., Director of Vitalant Research Institute

Nareg Roubinian, M.D., M.P.H., Associate Professor, Laboratory Medicine, University of California, San Francisco

10:15 – 10:45 a.m.
-
Keynote Speaker

Steven Spitalnik, M.D., Co-Director of the Laboratory of Transfusion Biology and Professor of Pathology & Cell Biology, Columbia University Medical Center

10:45 a.m. – 12:15 p.m.
-
GENERAL SESSION

Blood Donors and the Supply: Diversifying, while Maintaining the Donor Pool, Donor Selection, and Optimizing Blood Availability and Safety

10:45 – 11:15 a.m.
Barbara Bryant, M.D., Chief, Department of Transfusion Medicine, NIH Clinical Center

Merlyn Sayers, Ph.D., President & CEO, Carter BloodCare


Optimizing Transfusion Outcomes for Recipients: Clinical Research, Randomized Clinical Trials and Pragmatic Trials, Patient Blood Management, Observational Epidemiology

11:15 – 11:45 a.m.
Cassandra Josephson, M.D., Hawkins Family Endowed Professor and Director of the Johns Hopkins All Children’s Cancer & Blood Disorders Institute

Darrell Triulzi, M.D., Director, Division of Transfusion Medicine, Department of Pathology and Medical Director, Clinical Services Vitalant-Pittsburgh


Emerging Infections: Impact on Blood Science, the Blood Supply, Safety, and Public Health

11:45 a.m. – 12:15 p.m.
Evan Bloch, MBChB, M.S., Associate Professor of Pathology, Johns Hopkins University School of Medicine

Louis Katz, M.D., Emeritus Chief Medical Officer, ImpactLife Blood Services

12:15 – 12:45 p.m.
-
Lunch Break

12:45 – 1:45 p.m.
-
Working Group Breakout #1: Concurrent Sessions

  • Blood donors and the supply
  • Optimizing transfusion outcomes for recipients
  • Emerging infections

1:45 – 2:00 p.m.
-
Break

2:00 – 3:00 p.m.
-
Concluding Statements from Each Working Group

Blood Donors and the Supply: Diversifying, While Maintaining the Donor Pool, Donor Selection, and Optimizing Blood Availability and Safety

2:00 – 2:20 p.m.
Moderators: Barbara Bryant, M.D., Chief, Department of Transfusion Medicine, NIH Clinical Center, and Merlyn Sayers, Ph.D., President & CEO, Carter BloodCare

Optimizing Transfusion Outcomes for Recipients: Clinical Research, Randomized Clinical Trials and Pragmatic Trials, Patient Blood Management, Observational Epidemiology

2:20 – 2:40 p.m.
Moderators: Cassandra Josephson, M.D., Hawkins Family Endowed Professor and Director of the Johns Hopkins All Children’s Cancer & Blood Disorders Institute, and Darrell Triulzi, M.D., Director, Division of Transfusion Medicine, Department of Pathology and Medical Director, Clinical Services Vitalant-Pittsburgh

Emerging infections: Impact on Blood Science, the Blood Supply, Safety, and Public Health

2:40 – 3:00 p.m.
Moderators: Evan Bloch, MBChB, M.S., Associate Professor of Pathology, Johns Hopkins University School of Medicine, and Louis Katz, M.D., Emeritus Chief Medical Officer, ImpactLife Blood Services

3:00 p.m.
-
ADJOURN

10:00 – 10:05 a.m.
-
Welcome and Introduction

Brian Custer, Ph.D., M.P.H., Director of Vitalant Research Institute

Nareg Roubinian, M.D., M.P.H., Associate Professor, Laboratory Medicine, University of California, San Francisco

10:05 – 10:35 a.m.
-
Keynote Speaker

Dana Devine, Ph.D., Chief Scientist, Canadian Blood Services

10:35 a.m. – 12:05 p.m.
-
GENERAL SESSION

Mechanistic Aspects of Components and Transfusion: Omics, Effectiveness, Quality, and Safety

10:35 – 11:05 a.m.
Angelo D’Alessandro, Ph.D., Associate Professor, University of Colorado

Eldad Hod, M.D., Associate Professor of Pathology & Cell Biology, Columbia University Medical Center


New Methods in Transfusion Science: Data Science, Multifactorial Analyses, Use of Artificial Intelligence/Machine Learning

11:05 – 11:35 a.m.
Ruchika Goel, M.D., Associate Professor, Hematology/Oncology, SIU School of Medicine

Jansen Seheult, M.D., Senior Associate Consultant, Mayo Clinic


Donor and Blood Recipient Health Disparities in Transfusion Medicine

11:35 a.m. – 12:05 p.m.
Meghan Delaney, D.O., M.P.H., Chief, Division of Pathology & Laboratory Medicine and Director, Transfusion Medicine, Children’s National

Yvette Miller, M.D., Executive Medical Officer, Donor and Client Support Center, American Red Cross

12:05 – 12:35 p.m.
-
Lunch Break

12:35 – 1:35 p.m.
-
Working Group Breakout #2: Concurrent Sessions

  • Mechanistic aspects of components and transfusion
  • New methods in transfusion science
  • Donor and blood recipient health disparities

1:35 – 1:50 p.m.
-
Break

1:50 – 2:50 p.m.
-
Concluding Statements from Each Working Group

Mechanistic Aspects of Components and Transfusion: Omics, Effectiveness, Quality, and Safety

1:50 – 2:10 p.m.
Moderators: Angelo D’Alessandro, Ph.D., Associate Professor, University of Colorado, and Eldad Hod, M.D., Associate Professor of Pathology & Cell Biology, Columbia University Medical Center


New Methods in Transfusion Science: Data Science, Multifactorial Analyses, Use of Artificial Intelligence/Machine Learning

2:10 – 2:30 p.m.
Moderators: Ruchika Goel, M.D., Associate Professor, Hematology/Oncology, SIU School of Medicine, and Jansen Seheult, M.D., Senior Associate Consultant, Mayo Clinic


Donor and Blood Recipient Health Disparities in Transfusion Medicine

2:30 – 2:50 p.m.
Moderators: Meghan Delaney, D.O., M.P.H., Chief, Division of Pathology & Laboratory Medicine and Director, Transfusion Medicine, Children’s National, and Yvette Miller, M.D., Executive Medical Officer, Donor and Client Support Center, Red Cross

2:50 – 3:20 p.m.
-
Keynote Speaker

Michael Busch, M.D., Ph.D., Director Emeritus, Vitalant Research Institute and Professor of Laboratory Medicine at the University of California, San Francisco

3:20 – 3:30 p.m.
-
Closing Remarks

Brian Custer, Ph.D., M.P.H., Director of Vitalant Research Institute

Nareg Roubinian, M.D., M.P.H., Associate Professor, Laboratory Medicine, University of California, San Francisco

3:30 p.m.
-
ADJOURN